wallstreet, hedge funds/shorts will continue to pound the pps until Raj:
1. cuts expenses starting by pay/options
2. meaningful increase in revenue
4. show that SPPI-2012 and Apaziquone will MOST LIKELY be approved.
UNTIL THEN, we suffer
the company should be buying hand over fist at below 7 if they think the future is bright.
you are right zeus, may be they want to destroy the company and take it private at the cheap.
a smart CEO would do everything to protect the shareholders and the company, Raj is either CLUELESS or UNABLE, we need a smart and ruthless CEO who understands CRIMINAL WALLSTREET
so those 100 shares traded every nanosecond are probably by Millennium HF computers, these criminals can destroy any small company if they wanted.
tartiaboy, do you think SPPI can share SPI-2012 phase 2 results with BP before they are announced to the public. Also SPPI already met with the FDA regarding phase 3 protocols, wonder how did that go?
if Raj can come up with a deal of 75-100 mil upfront, that will eliminate most of the debt and put the shorts on notice and a short leach. Raj MUST come up with something BIG to justify his ASTRONOMICAL compensation.
he is not answering because the chemical weapons used in Vnam messed up his neurons.
how are we down more than 20% in 2014 after,
1. getting Belino approved and selling
2.stabilizing FUS sales, and now increasing
3.starting to sell marqibo with great potential expansion.
4.deciding GO SPI-2012 after meeting all phase 2 requirements.
I bet if we fire 60% of the work force (cut the dead wood), we will be profitable RIGHT NOW, and you add sale increases, the stock price will EXPLODE. Raj needs to STOP using sppi as his ATM, how much more money does he need, he made out with TENS OF MILLIONS of dollars while the market cap has decreased by 700 millions (from 17+ to 6+). I hope investors let Raj and the BOD know that we are sick and tired of being fleeced in the daylight while there are making MILLIONS.
if the left wing party Syriza in Greece wins (they are well ahead in the polls) in next month election, Greece will pull out of the EU, because Syriza said that they would not go along the austerity imposed on the them by Germany. Should that happens (highly probable), we will have worldwide stockmarket mayhem, and Greek stocks would suffer the most. I predict NMM to go to $1, and NBG to $0.10.
the elite and banksters in Greece stole hundreds of billions of dollars, and the poor population is holding the bag, forced to repay the big banks= this story will rock the market, and like they say in ole ENGLAND: SPPI is as safe as houses.
Angela Merkel has just said that she will accept Greece exiting Europe Union, the left wing party is expected to win the election in 3 weeks, this is why the Euro is sinking. I am predicting the Greek stock market to collapse, and NMM to go below $1.
shorting stocks is against my principles, I only buy stocks that I like. As far as Greece is concerned, they will be better off if the they the EU. The elite and the banksters have destroyed the working class, by stealing hundreds of billions, and the people are paying it with austerity, 50% unemployment and an explosion in suicides. Crony capitalism lead by Goldman Sacks and JP Morgan (and others)has wrecked the world economy. I think you are going to see a big worldwide revolution against the thieves of wallstreet, who invented nothing but financial engineering: to cheat-steal-pillage.
b.greeny, is the only thing you do all day is troll from one MB to another #$%$ about CEOs, why don' t you get a life greeny boy.
“We are pleased with the Phase 2 results (N= 156) that we have seen and have strong conviction that we can "We have a very exciting novel biologic drug in this very large market,” said Rajesh C. Shrotriya, MD, Chairman and Chief Executive Officer of Spectrum Pharmaceuticals. “SPI-2012 is built upon the 3rd generation LAPSCOVERY technology of Hanmi Pharm. Co. that differentiates our drug from the existing drugs used to treat neutropenia, and it could potentially have advantages relating to more rapid and potent granulocyte (white blood cell) recovery compared to pegylated filgrastim. SPI-2012 is one of the highest priorities at Spectrum because of the value of this opportunity with its successful commercialization. We will use the learnings from our Phase 2 enrollment to accelerate Phase 3 enrollment and, if SPI-2012 is approved, use our specialized commercial expertise to get this drug to market as soon as possible. The decision to go into Phase 3 with SPI-2012 is a landmark decision in Spectrum’s history, and significantly enhances the future growth prospects of the company.”
when the results are released we will find if it was warranted to use phrases like: strong conviction....potentially have advantages......exciting novel biologic drug.....